First-Ever Day to End Fistula Brings Attention to Progress, Challenges

 Marking the first-ever International Day to End Obstetric Fistula on May 23, Direct Relief is intensifying its decade-long efforts to prevent...

Johnson & Johnson Pharmaceuticals Segment Poised to Continue Driving Growth with More than 10 Potential New Product Filings by 2017

At a meeting today with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced...

Aeterna Zentaris: Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcoming ASCO Meeting

QUÉBEC CITY, May 23, 2013 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that the...

Positive Animal Data Presented at EuroPCR Sets Stage for Advancing Neovasc's Tiara(TM) Transcatheter Mitral Valve into Human Trials

-Longer-Term Animal Data Suggests Tiara Device for the Transcatheter Treatment of Mitral Valve Disease Appears Safe and Well Tolerated TSX...

Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML)

 Inhibikase Therapeutics, Inc., an emerging leader in infectious disease treatments, announced today that it will present new results on its...

MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy

 MedVantx, Inc., the company that has pioneered a unique direct to consumer pharmaceutical distribution channel announced today the Company has...

Thank You Metro Detroit! 30,000 took part in the 22nd Annual Komen Detroit Race for the Cure®, May 18. Fundraising Continues through July 1.

A crowd of 30,000 participated in this year's 22nd Annual Susan G. Komen Detroit Race for the Cure®, held Saturday, May 18, at Comerica Park....

Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at...

Biorem Reports 3rd Consecutive Quarter with Positive EBITDA

GUELPH, ON, May 23, 2013 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for the three month period...

Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment

Pusan National University Yangsan Hospital, in collaboration with SillaJen, Inc., a private biotherapeutics and contract research company focused...

Former Joint Commission Executive To Lead TeleTracking Consulting Services

 Nanne Finis, RN, MS, formerly executive director of solutions services for Joint Commission Resources (JCR), has joined TeleTracking...

Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease

 Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug Application (IND) to evaluate OMS824 in Huntington's...

Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference

EarlySense, the market leader in Proactive Patient Care Solutions™, announced today that the prize for 'Best Novel Idea' at the 8th Annual...

Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition

SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total...

Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share

 Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that it has committed to waive down the Acceptance Threshold from 90...

OncoGenex Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination with Chemotherapy in Advanced Squamous Cell Lung Cancer

 OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Cedar™ clinical trial, an...

Cycle Stuff Direct Looks at Cycle Fitness Nutrition

Everyone knows that cycling is fantastic for our overall fitness and health, but what about nutrition and how it has an impact on cycle training?...

PAREXEL International To Present At Jefferies Healthcare Conference

 PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Healthcare Conference in New...

BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress

 BioLife Solutions, Inc. (OTC:BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and...

InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group

InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), the leader in embolic protection stents, today announced new...